# The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:

> **NCT05242783** · NA · COMPLETED · sponsor: **Wael Elbanna Clinic** · enrollment: 99 (actual)

## Conditions studied

- Myoma

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT05242783
- **Lead sponsor:** Wael Elbanna Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2024-03-29
- **Final completion:** 2024-06-20
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05242783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05242783, "The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05242783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*